efmoroctocog alfa sold brand name elocta among others medication treatment prophylaxis bleeding people hemophilia efmoroctocog alfa recombinant human coagulation factor viii fc fusion protein produced recombinant dna technology human embryonic kidney hek cell approved medical use united states june use european union november united states efmoroctocog alfa eloctate indicated adults children hemophilia ondemand treatment control bleeding episodes perioperative management routine prophylaxis prevent reduce frequency bleeding european union efmoroctocog alfa elocta indicated treatment prophylaxis bleeding people haemophilia drug article relating blood blood forming organs stub help wikipedia expanding httpsenwikipediaorgwikiefmoroctocogalfa